Literature DB >> 29637867

ACP5: Its Structure, Distribution, Regulation and Novel Functions.

Xin Ren1,2, Wen-Hua Shan1, Lu-Lu Wei3, Chan-Chan Gong3, Dong-Sheng Pei1,3,4.   

Abstract

BACKGROUND: Tartrate-resistant acid phosphatase 5 (ACP5) is an evolutionarily conserved and multifunctional protein that is involved in generations of reactive oxygen species, normal bone development, osteoblast regulation and macrophage function, affecting a series of pathways, as well as reflecting bone resorption and osteoclast activity.
METHODS: Literature searches, systematic reviews and assessments about the structure, distribution, regulation and novel functions of ACP5 were performed in this review from PubMed and Medline databases.
RESULTS: Studies demonstrate that RANKL can increase the expression of ACP5 through NFATc1 and c-Fos to accelerate osteoclastogenesis, which also can be regulated by many regulators. Based on the aforementioned information, it is shown that ACP5, together with the phosphatase activity, can medicate the progression and development of human genetic diseases and cancer.
CONCLUSION: As a novel target, ACP5 plays a critical role in preventing, monitoring and treating various kinds of tumors, as well as accelerating the development of a promising therapeutic strategy for human genetic diseases. However, the explicit mechanism between ACP5 and cancer is not so clear. It is necessary and significant for us to pay more in-depth attention. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  ACP5; NFATc1; c-Fos; cancer; genetic diseases; phosphatase activity; regulating factors.

Mesh:

Substances:

Year:  2018        PMID: 29637867     DOI: 10.2174/1871520618666180411123447

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  6 in total

1.  Progranulin, a moderator of estrogen/estrogen receptor α binding, regulates bone homeostasis through PERK/p-eIF2 signaling pathway.

Authors:  Yuyou Yang; Naibo Feng; Li Liang; Rong Jiang; Yiming Pan; Nana Geng; Mengtian Fan; Xiaoli Li; Fengjin Guo
Journal:  J Mol Med (Berl)       Date:  2022-07-15       Impact factor: 5.606

2.  Duhuo Jisheng Decoction inhibits the activity of osteoclasts in osteonecrosis of the femoral head via regulation of the RELA/AKT1 axis.

Authors:  Tao Xing; Yongqiang Zhao; Jun Zhao; Zhenxing Jiang; Yingshuan Zhang; Shenghua Li
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

3.  Tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis by modulating β-catenin signaling.

Authors:  Yinan Hu; Qi Wang; Jun Yu; Qing Zhou; Yanhan Deng; Juan Liu; Lei Zhang; Yongjian Xu; Weining Xiong; Yi Wang
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

4.  ZEB1 regulates bone metabolism in osteoporotic rats through inducing POLDIP2 transcription.

Authors:  Xianwei Zhu; Fei Yan; Lipeng Liu; Qun Huang
Journal:  J Orthop Surg Res       Date:  2022-09-19       Impact factor: 2.677

5.  Characterisation of ACP5 missense mutations encoding tartrate-resistant acid phosphatase associated with spondyloenchondrodysplasia.

Authors:  Janani Ramesh; Latha K Parthasarathy; Anthony J Janckila; Farhana Begum; Ramya Murugan; Balakumar P S S Murthy; Rif S El-Mallakh; Ranga N Parthasarathy; Bhuvarahamurthy Venugopal
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

6.  Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy.

Authors:  Hang Ji; Yixu Ba; Shuai Ma; Kuiyuan Hou; Shan Mi; Xin Gao; Jiaqi Jin; Qin Gong; Ting Liu; Fang Wang; Zhihui Liu; Shupeng Li; Jianyang Du; Shaoshan Hu
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.